Your browser doesn't support javascript.
loading
Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells.
Dobson, Lucianne; Träger, Ulrike; Farmer, Ruth; Hayardeny, Liat; Loupe, Pippa; Hayden, Michael R; Tabrizi, Sarah J.
Afiliação
  • Dobson L; Department of Neurodegenerative Diseases, University College London, Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK.
  • Träger U; Department of Neurodegenerative Diseases, University College London, Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK.
  • Farmer R; Now at German Cancer Research Centre, Immune Tolerance, Tumour Immunology Program, Heidelberg, Germany.
  • Hayardeny L; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
  • Loupe P; Teva Pharmaceuticals, Research and Development, Netanya, Israel.
  • Hayden MR; Teva Pharmaceuticals, Research and Development, Netanya, Israel.
  • Tabrizi SJ; Teva Pharmaceuticals, Research and Development, Netanya, Israel.
J Neurochem ; 137(5): 782-94, 2016 06.
Article em En | MEDLINE | ID: mdl-26823290
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Citocinas / Doença de Huntington / Quinolonas / Células Mieloides Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Citocinas / Doença de Huntington / Quinolonas / Células Mieloides Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article